New Update:
- ADM, a major player in commodities, has announced a partnership with Japanese company Asahi Group to market and distribute a postbiotic ingredient focusing on sleep, stress, and mood. The product, Lactobacillus gasseri, backed by eight clinical trials, will be available in North America, Europe, and Asia starting in March.
- This innovative ingredient, developed through extensive research on lactic acid bacteria, will be utilized in various applications such as functional food, beverages, and supplements, catering to the growing consumer interest in gut health.
- With a surge in gut health products flooding the market, manufacturers are seizing the opportunity to meet consumer demands for wellness-enhancing products.
Insightful Perspective:
Mark Lotsch, ADM’s president of global health and wellness, expressed excitement about the collaboration with Asahi Group and the potential for creating products that promote consumer well-being. He highlighted the rising popularity of stress, mood, and sleep-related wellness products, emphasizing their crucial role in overall health.
Data from Euromonitor revealed a significant annual growth in products targeting mood and relaxation, indicating a lucrative market for such offerings.
Asahi Group’s L. gasseri ingredient reportedly shows promising results in improving sleep quality and efficiency, aligning with the increasing demand for products that address holistic wellness.
ADM’s commitment to gut health is evident through its range of probiotic ingredients aimed at enhancing digestive health and immunity. Their collaboration with Brightseed to utilize AI for developing microbiome-improving ingredients further underscores their dedication to innovation.
Advocates of postbiotics emphasize their potential in boosting the immune system and reducing inflammation in the gut. The projected growth of the postbiotics market, estimated to reach $3 billion by 2031, reflects the increasing recognition of their benefits.